Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QST evaluation of single escalating subcutaneous doses of Halneuron in healthy volunteers
2022-500318-24-00Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tetrodotoxin in pain (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Change from baseline in individual QST sensory measurements at 1 hour post-dose. Started Aug 2023; status: completed.
02
Drugs
tetrodotoxin
03
Conditions
pain
Beyond the preview
Go deeper on 2022-500318-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500318-24-00.